Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.

författare

Kylie M Drake

Nicholas W Morrell

Micheala A Aldred

publicerad i: American Journal of Respiratory Cell and Molecular Biology

utgivningsår: 2013-09-01

huvudämne: högt blodtryck

Refererar artiklar 51

Datum

Titel

Författare

2012-08-23

Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension

James David West, John H. Newman, Emma K. Larkin
2012-07

The pharmacological treatment of pulmonary arterial hypertension
2012-03-15

Human primary lung endothelial cells in culture

Suzy A A Comhair, Serpil C. Erzurum
2012-08-01

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry

Robyn J Barst
2011-09-15

Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8

Kylie M Drake, Suzy A A Comhair
2011-03-01

Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective
2011-10-11

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension

Richard C Trembath, Rajiv Machado, Laura Southgate, Graham M Lord, Marc Humbert
2011-07-07

Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
2011-01-13

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
2010-11-01

Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension
2010-09-22

New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view

José M López-Novoa, Laura Vicente-Vicente
2010-10-01

Cellular mechanisms of aminoglycoside ototoxicity
2010-08-01

Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha
2010-01-20

Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension
2010-09-24

Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.

Jessica M. Boname, Hannah J Durrington, David J. Blackbourn, Gerard B Nash, Paul J Lehner
2010-01-07

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

David Montani, Olivier Sitbon, Marc Humbert, Gérald Simonneau, Dermot S. O'Callaghan, Benjamin Sztrymf, Florence Coulet, Barbara Girerd, Florent Soubrier
2010-11-11

Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension

Christopher G. Scott
2010-07-09

Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis

Teresinha Leal, Francois Vermeulen
2009-06-01

Updated clinical classification of pulmonary hypertension.

Mark T Gladwin
2009-06-01

Genetics and genomics of pulmonary arterial hypertension.

John H. Newman, Oliver Eickelberg
2009-06-05

Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells

Nicholas W Morrell, Richard C Trembath
2009-02-11

A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension
2009-07-23

Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension

Elaine Soon, Mark Southwood, Werner Seeger, Nicholas W Morrell, Joanna Pepke-Zaba, Robert Voswinckel, Rafia Al-Lamki, Mark Toshner, Jay Suntharalingam, Andrew Exley
2008-08-01

Therapeutic advances in pulmonary arterial hypertension

David Montani, Xavier Jais, Olivier Sitbon, Marc Humbert, Gérald Simonneau
2008-09-05

High levels of hyaluronan in idiopathic pulmonary arterial hypertension

Carol Farver
2008-07-03

SMAD proteins control DROSHA-mediated microRNA maturation
2008-02-07

Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension

Carol Farver
2008-07-21

Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue

Richard C Trembath, Nicholas W Morrell
2008-08-20

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

Hannah Blau
2008-03-20

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation

David Montani, Rogério Souza, Xavier Jais, Olivier Sitbon, Marc Humbert, Gérald Simonneau, Benjamin Sztrymf, Florence Coulet, Barbara Girerd, Florent Soubrier
2008-03-04

Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension

Victoria James, Nicholas W Morrell, Richard C Trembath
2008-01-01

Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1

Artikel - wd:Q37298006

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer